BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11067678)

  • 1. Medical devices; effective date of requirement for premarket approval for a class III preamendments obstetrical and gynecological device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jul; 65(129):41330-2. PubMed ID: 11067678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; effective date of requirement for premarket approval for three class III preamendments devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Aug; 63(159):44177-81. PubMed ID: 10184983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Jul; 63(146):40673-7. PubMed ID: 10181520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; effective date of requirement for premarket approval for three class III preamendments physical medicine devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Jul; 63(146):40677-81. PubMed ID: 10181521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General hospital and personal use devices; premarket approval of the infant radiant warmer--FDA. Proposed rule.
    Fed Regist; 1986 Jan; 51(10):1910-5. PubMed ID: 10275304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dental devices; effective date of requirement for premarket approval; temporomandibular joint prostheses--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(250):71743-6. PubMed ID: 10339055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; intent to initiate proceedings to establish effective dates of requirement for premarket approval for 31 class III preamendments devices--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1989 Jan; 54(4):550-2. PubMed ID: 10291347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; substantial equivalence; 510(K) summaries and 510(K) statements; class III summaries; confidentiality of information--FDA. Final rule.
    Fed Regist; 1994 Dec; 59(239):64287-96. PubMed ID: 10139433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; retention of three preamendment class III devices in class III--FDA. Final rule.
    Fed Regist; 1998 Jun; 63(125):35516-7. PubMed ID: 10181050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; classification/reclassification of immunohistochemistry reagents and kits--FDA. Final rule.
    Fed Regist; 1998 Jun; 63(106):30132-42. PubMed ID: 10179865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
    Yin L
    J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule.
    Fed Regist; 1998 Oct; 63(195):54042-4. PubMed ID: 10185825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric and gynecologic devices; reclassification and classification of medical devices used for in vitro fertilization and related assisted reproduction procedures--FDA. Final rule.
    Fed Regist; 1998 Sep; 63(175):48428-37. PubMed ID: 10182829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; reclassification and codification of vitamin D test system--FDA. Final rule.
    Fed Regist; 1998 Jul; 63(145):40364-6. PubMed ID: 10181714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.